Literature DB >> 15082139

Panic disorder and pain in a national sample of persons living with HIV.

Jennie C I Tsao1, Aram Dobalian, Bruce D Naliboff.   

Abstract

Research to date has focused on depression and co-existing pain in HIV with relatively little attention devoted to the study of anxiety disorders and concurrent pain. We therefore examined the relationships among panic disorder, posttraumatic stress disorder (PTSD), major depression and pain in a US national sample of persons with HIV, controlling for key sociodemographic and clinical variables, including HIV disease status. The study sample comprised 1489 HIV+ individuals (representing 219 667 persons). In multivariate analyses, panic disorder showed a strong association with pain ( beta= -15.70; 99% confidence interval [CI]=-21.33 to -10.08; P<0.001, which was significantly greater than PTSD (P=0.002) but only marginally greater than major depression (P=0.002). Longitudinal analyses of the three psychological disorders revealed that increasing pain from baseline to follow-up (an approximately 6-month period) was associated with panic disorder only (relative risk ratio=2.18, 99% CI=1.02-4.69; P<0.01), after controlling for baseline pain scores, baseline HIV disease status and change in disease stage across time. We discuss specific mechanisms by which clinical anxiety and chronic pain may be mutually maintained in HIV+ individuals. Our findings suggest that panic disorder, as well as PTSD and major depression are associated with greater pain in HIV patients.

Entities:  

Mesh:

Year:  2004        PMID: 15082139     DOI: 10.1016/j.pain.2004.02.001

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  24 in total

1.  Sex differences in pain and misuse of prescription analgesics among persons with HIV.

Authors:  Jennie C I Tsao; Judith A Stein; Aram Dobalian
Journal:  Pain Med       Date:  2010-04-29       Impact factor: 3.750

2.  Hepatitis C virus infection is associated with painful symptoms in HIV-infected adults.

Authors:  Judith I Tsui; Debbie M Cheng; Howard Libman; Carly Bridden; Jeffrey Samet
Journal:  AIDS Care       Date:  2012-01-24

3.  Chronic pain and hepatitis C virus infection in opioid dependent injection drug users.

Authors:  Judith I Tsui; Debra S Herman; Malyna Kettavong; Bradley J Anderson; Michael D Stein
Journal:  J Addict Dis       Date:  2011-04

Review 4.  Safety considerations in drug treatment of depression in HIV-positive patients: an updated review.

Authors:  Crystal C Watkins; Andrew A Pieper; Glenn J Treisman
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

5.  HIV stigma among substance abusing people living with HIV/AIDS: implications for HIV treatment.

Authors:  Maria A Levi-Minzi; Hilary L Surratt
Journal:  AIDS Patient Care STDS       Date:  2014-07-01       Impact factor: 5.078

Review 6.  Affective disorders in patients with HIV infection: impact of antiretroviral therapy.

Authors:  Gabriele Arendt
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 7.  Anxiety and medical disorders.

Authors:  Jacqueline E Muller; Liezl Koen; Dan J Stein
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

8.  Medication Adherence and HIV Symptom Distress in Relation to Panic Disorder Among HIV-Positive Adults Managing Opioid Dependence.

Authors:  Jesse D Kosiba; Adam Gonzalez; Conall O'Cleirigh; Steven A Safren
Journal:  Cognit Ther Res       Date:  2014-08

9.  Feasibility and preliminary efficacy of a web-based smoking cessation intervention for HIV-infected smokers: a randomized controlled trial.

Authors:  Jonathan Shuter; Daniela A Morales; Shannon E Considine-Dunn; Lawrence C An; Cassandra A Stanton
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

10.  Relationships among anxious symptomatology, anxiety sensitivity and laboratory pain responsivity in children.

Authors:  Jennie C I Tsao; Qian Lu; Su C Kim; Lonnie K Zeltzer
Journal:  Cogn Behav Ther       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.